Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Lithium: An Old Drug for New Therapeutic Strategy for Alzheimer's Disease and Related Dementia.
Journal: Neuro-degenerative diseases
Published: March 23, 2023
Lithium Provides Broad Therapeutic Benefits in an Alzheimer's Disease Mouse Model.
Journal: Journal of Alzheimer's disease : JAD
Published: November 28, 2022
Extrasynaptic NMDA receptors in acute and chronic excitotoxicity: implications for preventive treatments of ischemic stroke and late-onset Alzheimer's disease.
Journal: Molecular neurodegeneration
Published: October 12, 2022
Inhibition of Glycogen Synthase Kinase-3: An Emerging Target in the Treatment of Traumatic Brain Injury.
Journal: Journal of neurotrauma
Published: March 17, 2016
An emerging role of cGMP in the treatment of schizophrenia: A review.
Journal: Schizophrenia research
Published: August 18, 2015
Are NMDA receptor antagonists beneficial in the treatment of schizophrenia?
Journal: Journal of psychiatric research
Published: November 14, 2013
Four weeks lithium treatment alters neuronal dendrites in the rat hippocampus.
Journal: The international journal of neuropsychopharmacology
Published: January 22, 2013
Effects of 4-weeks of treatment with lithium and olanzapine on long-term potentiation in hippocampal area CA1.
Journal: Neuroscience letters
Published: November 02, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026